scispace - formally typeset
E

Elisabeth Rothbauer

Researcher at Free University of Berlin

Publications -  5
Citations -  231

Elisabeth Rothbauer is an academic researcher from Free University of Berlin. The author has contributed to research in topics: Epidermal growth factor & Growth factor. The author has an hindex of 5, co-authored 5 publications receiving 229 citations. Previous affiliations of Elisabeth Rothbauer include Ludwig Maximilian University of Munich.

Papers
More filters
Book ChapterDOI

Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options.

TL;DR: Patients with invasive gastric or colorectal carcinomas might benefit from therapies specifically blocking EGFR-mediated signal transduction, as it has been shown that increased tumor EGF receptor levels were associated with poor prognosis in gastric cancer patients with tumors localized distal from the cardia.
Journal ArticleDOI

Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels.

TL;DR: The epidermal growth factor receptor/ligand system appears to be involved in tumor development and tumor progression of colorectal carcinomas, with prognostic implication especially in patients with invasive rectal cancer.
Journal Article

Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients.

TL;DR: Gastric carcinomas with increased EGF receptors might be a possible target for anticancer strategies blocking the EGF receptor/ligand pathway.
Journal ArticleDOI

Increased epidermal growth factor receptors in gastric carcinomas.

TL;DR: It is concluded that relative overexpression of epidermal growth factor receptors occurs in a fraction of gastric carcinomas.
Journal ArticleDOI

Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas.

TL;DR: It is concluded that increased expression of EGF-receptors is infrequent in colonic adenocarcinomas and increased production of E GF-like growth factors may frequently occur but seems to be associated with tumor progression rather than with premalignant lesions as represented by adenomas.